HBOC syndrome accounts for 5–7% of all cases of breast cancer, and patients carrying the mutation have a lifetime risk for developing breast cancer of 50–80% and 30–50% for ovarian cancer (both BRCA1 and BRCA2) [3]. The gene discussed is BRCA2; the disease is breast cancer.